The COVID-19 Antigen Rapid Test (Rapid SARS-CoV-2 Antigen Test Card) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 antigens present in human nasal, nasopharyngeal, or oropharyngeal specimens.
Maintain viability of viruses chlamydiae, mycoplasma and urealasma with top quality transport and storage media that comes in four versatile formulations.
Rapid 2019-nCoV IgG/IgM Combo Diagnostic Test Cards to COVID-19 is a rapid immunochromatographic test designed for the qualitative determination of IgG and IgM antibodies to 2019 novel coronavirus (2019-nCoV, SARS-CoV-2) in human serum, plasma, or whole blood.
SARS-CoV-2 Proteome Microarray with 4,883 virus specific peptides printed in duplicate. The microarray can be used for epitope mapping, serum screening, or biomarker discovery.
Maintain organism viability and counts for verification studies, quality control procedures, and repeat testing of viruses chlamydiae, mycoplasma and ureaplasma with quality media, proven collection and transport tools, and safe, reliable packaging.
For the screening of patients previously infected, to either; confirm infection, monitor the course of disease, or to draw epidemiological conclusions. Includes all additional reagents required to perform each test.